Loading...
XTSXBRM
Market cap35mUSD
Dec 23, Last price  
3.16CAD
1D
0.64%
1Q
34.47%
Jan 2017
1,216.67%
Name

Biorem Inc

Chart & Performance

D1W1MN
XTSX:BRM chart
P/E
23.37
P/S
2.02
EPS
0.14
Div Yield, %
0.00%
Shrs. gr., 5y
-15.19%
Rev. gr., 5y
0.68%
Revenues
25m
-12.81%
2,42110,712,85412,008,3139,469,95514,400,07118,878,21817,359,55612,045,19515,418,32019,596,41810,683,14216,880,17315,896,14622,558,27024,332,82720,649,11124,375,34324,477,99728,862,97225,165,448
Net income
2m
+35.11%
-25,221343,886-769,674-3,001,422-432,236-502,838-3,137,781-3,369,416-829,992717,625-1,722,2101,688,851547,2751,530,1164,665,763-1,302,4242,088,8441,297,3371,613,0572,179,386
CFO
490k
-66.09%
-23,398-1,374,7431,151,467-2,069,790-2,657,7742,123,311-1,857,163905,259-530,207733,706-445,5932,149,387-777,7781,173,251-2,5262,527,6353,335,4103,781,8021,444,914490,033
Earnings
Apr 09, 2025

Profile

BioRem Inc., a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs. The company also provides multi-stage systems to remove odors from various municipal/urban wastewater treatment processes; biogas desulfurization systems; dry scrubber adsorption systems; and cannabis odor control systems. In addition, it offers biological processes and testing services; media sampling and analysis; system review and inspections; and media replacements and spare parts. The company operates in Canada, the United States, China, and internationally. BioRem Inc. was founded in 1990 and is headquartered in Puslinch, Canada.
IPO date
Apr 23, 2004
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
25,165
-12.81%
28,863
17.91%
24,478
0.42%
Cost of revenue
22,079
25,984
22,169
Unusual Expense (Income)
NOPBT
3,086
2,879
2,309
NOPBT Margin
12.26%
9.97%
9.43%
Operating Taxes
610
770
737
Tax Rate
19.76%
26.76%
31.92%
NOPAT
2,476
2,108
1,572
Net income
2,179
35.11%
1,613
24.34%
1,297
-37.89%
Dividends
Dividend yield
Proceeds from repurchase of equity
69
2
(7,317)
BB yield
-0.40%
-0.01%
21.73%
Debt
Debt current
723
1,458
1,694
Long-term debt
4,671
3,758
4,627
Deferred revenue
Other long-term liabilities
Net debt
3,102
1,441
1,850
Cash flow
Cash from operating activities
490
1,445
3,782
CAPEX
(553)
(203)
(76)
Cash from investing activities
(553)
(203)
(76)
Cash from financing activities
(1,329)
(952)
(7,556)
FCF
(1,274)
(141)
3,490
Balance
Cash
2,292
3,775
4,471
Long term investments
Excess cash
1,034
2,332
3,247
Stockholders' equity
4,351
2,260
(205)
Invested Capital
9,871
6,113
7,389
ROIC
30.98%
31.23%
22.51%
ROCE
28.30%
34.38%
32.14%
EV
Common stock shares outstanding
17,107
17,555
37,411
Price
1.00
13.64%
0.88
-2.22%
0.90
66.67%
Market cap
17,107
10.74%
15,448
-54.12%
33,670
57.81%
EV
20,209
16,889
35,520
EBITDA
3,469
3,229
2,652
EV/EBITDA
5.83
5.23
13.39
Interest
273
257
36
Interest/NOPBT
8.86%
8.93%
1.55%